Advertisement
UK markets close in 2 hours 24 minutes
  • FTSE 100

    8,034.36
    +10.49 (+0.13%)
     
  • FTSE 250

    19,696.34
    +96.95 (+0.49%)
     
  • AIM

    753.29
    +4.11 (+0.55%)
     
  • GBP/EUR

    1.1609
    +0.0020 (+0.17%)
     
  • GBP/USD

    1.2389
    +0.0039 (+0.31%)
     
  • Bitcoin GBP

    53,392.98
    -30.82 (-0.06%)
     
  • CMC Crypto 200

    1,419.35
    +4.59 (+0.32%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    80.99
    -0.91 (-1.11%)
     
  • GOLD FUTURES

    2,323.80
    -22.60 (-0.96%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,055.90
    +195.10 (+1.09%)
     
  • CAC 40

    8,080.45
    +40.09 (+0.50%)
     

Worldwide Industry for Companion Diagnostics to 2024 - The Rising Use of Personalized Medicine is Driving Growth

Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "Global Companion Diagnostics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The companion diagnostics market is poised to grow by $5.74 billion during 2020-2024 progressing at a CAGR of 26% during the forecast period.

This report on the companion diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the rising use of personalized medicine, increased industry collaborations, and growing investments in life sciences sector.

The companion diagnostics market analysis includes end-user segment and geographical landscapes. This study identifies the rising occurrence of breast cancer as one of the prime reasons driving the companion diagnostics market growth during the next few years. Also, increase in product approvals to treat cancer and growing importance for promotional activities will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

This report on the companion diagnostics market covers the following areas:

  • Companion diagnostics market sizing

  • Companion diagnostics market forecast

  • Companion diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., bioMerieux SA, F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc. Also, the companion diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

The market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Key Topics Covered:

1. Executive Summary

  • Market Overview

ADVERTISEMENT

2. Market Landscape

  • Market ecosystem

  • Value chain analysis

3. Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019-2024

4. Five Forces Analysis

  • Five Forces Summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

5. Market Segmentation by End-user

  • Market segments

  • Comparison by End-user

  • Life science - Market size and forecast 2019-2024

  • Health centers - Market size and forecast 2019-2024

  • Others - Market size and forecast 2019-2024

  • Market opportunity by End-user

6. Customer Landscape

7. Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Volume drivers - Demand led growth

  • Market challenges

  • Market trends

8. Vendor Landscape

  • Overview

  • Vendor landscape

  • Landscape disruption

9. Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Abbott Laboratories

  • Agilent Technologies Inc.

  • bioMerieux SA

  • F. Hoffmann-La Roche Ltd.

  • Illumina Inc.

  • Myriad Genetics Inc.

  • QIAGEN NV

  • Siemens Healthineers AG

  • Sysmex Corp.

  • Thermo Fisher Scientific Inc.

10. Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/i6nw5q

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900